Liposomal amphotericin B eye drops to treat fungal keratitis: Physico-chemical and formulation stability

International Journal of Pharmaceutics

Volumn 344, Issue 1-2, 2007, Pages 150-153

  Morand, K ^a   Bartoletti, A C ^a,b   Bochot, A ^b   Barratt, G ^b   Brandely, M L ^a   Chast, F ^a  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Amphotericin B; Eye drops; Fungal infections; Liposomes

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; DEOXYCHOLIC ACID; LIPOSOME; PHOSPHATIDYLCHOLINE;

ARTICLE; CORNEA; DRUG STABILITY; ENVIRONMENTAL TEMPERATURE; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL PHARMACY; HUMAN; KERATOMYCOSIS; LIGHT SCATTERING; PATIENT COMPLIANCE; PRIORITY JOURNAL; ROOM TEMPERATURE; SHELF LIFE;

ADMINISTRATION, TOPICAL; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEAL ULCER; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; EYE INFECTIONS, FUNGAL; HUMANS; LIGHT; OPHTHALMIC SOLUTIONS; SCATTERING, RADIATION; TEMPERATURE;

EID: 34648828605     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.04.028     Document Type: Article

References (17)

1. Alak A., Moy S., and Bekersky I. A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of Ambisome, a liposomal amphotericin B formulation. Ther. Drug Monit. 18 (1996) 604-609
2. Barza M., Baum J., Tremblay C., Szoka F., and D'Amico D.J. Ocular toxicity of intravitreally injected liposomal amphotericin B in rhesus monkeys. Am. J. Ophthalmol. 100 (1985) 259-263
3. Cannon J.P., Fiscella R., Pattharachayakul S., Garey K.W., De Alba F., Piscitelli S., Edward D.P., and Danziger L.H. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2112-2117
4. Cohen T., Sauvageon-Martre H., Brossard D., D'Hermies F., Bardin C., Chast F., and Chaumeil J.C. Amphotericin B eye drops as a lipidic emulsion. Int. J. Pharm. 137 (1996) 249-254
5. Deray G. Amphotericin B nephrotoxicity. J. Antimicrob. Chemother. 49 (2002) 37-41
6. Ebrahim S., Peyman G.A., and Lee P.J. Applications of liposomes in ophthalmology. Surv. Ophthalmol. 50 (2005) 167-182
7. Eldem T., and Arican-Cellat N. High performance liquid chromatographic determination of amphotericin B in a liposomal pharmaceutical product and validation of the assay. J. Chromatogr. Sci. 38 (2000) 338-344
8. Goldblum D., Frueh B., Zimmerli S., and Böhnke M. Treatment of postkeratitis fusarium endophtalmitis with amphotericin B lipid complex. Cornea 19 (2000) 853-856
9. Kaur I.P., Garg A., Singla A.K., and Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int. J. Pharm. 269 (2004) 1-14
10. Pleyer U., Grammer J., Pleyer J.H., Kosmidis P., Friess D., Schmidt K.H., and Thiel H.J. Amphotericin B bioavailibility in the cornea. Studies with local administration of liposome incorporated amphotericin B. Ophthalmology 92 (1995) 469-475
11. Sabra R., and Branch R.A. Amphotericin B nephrotoxicity. Drug. Saf. 5 (1990) 94-108
12. Sharkey P.K., Graybill J.R., Johnson E.S., Hausrath S.G., Pollard R.B., Kolokathis A., Mildvan D., Fan-Havard P., Eng R.H., Patterson T.F., Pottage J.C., Simberkokk M.S., Wolf J., Meyer R.D., Gupta R., Lee L.W., and Gordon D.S. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 22 (1996) 315-321
13. Schelenz S., and Goldsmith D.J. Aspergillus endophtalmitis: an unusual complication of disseminated infection in renal transplant patients. J. Infect. 47 (2003) 336-343
14. Takayama M., Itoh S., Nagasaki T., and Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin. Chim. Acta 79 (1977) 93-98
15. Thomas P.A. Fungal infections of the cornea. Eye 17 (2003) 852-862
16. Tremblay C., Barza M., Szoka F., Lahav M., and Baum J. Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits. Invest. Ophthalmol. Vis. Sci. 26 (1985) 711-718
17. Walsch T.J., Hiemenz J.W., Seibel N.L., Perfect J.R., Horwith G., Silber J.L., DiNubile M.J., Reboli A., Bow E., Lister J., and Anaissie E.J. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin. Infect. Dis. 26 (1998) 1383-1396